6Craig Serjeant. Justifying and establishing an intravenous additive service[ J ]. Aust. g. Pharm, 1979,9(4) : 124.
7Milkovich G. The role of the hospital pharmacist in control and antibiotic policy[J], Int J Agents, 2000 Nov, 16(3) :29i-294.
8Hcolihan RJ, Erickson BA. Strategies for reducing i.v. drug waste and coping with increased workload[J]. Hosp Pharm, 1987 Sep,22(9) :871-876.
9Bristor-Myer Squibb. Gatifloxacin (Tequin) :An advanced generation quinolone for the treatment of selected infectious diseases [M] .Glenview: Physicians Scientists Publishing CO, INC, 2000. 47.
10Wish R, Honeybourne D. Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract[J]. European Respir J, 1999, 14 ( 1 ): 221.
